{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:46:10Z","timestamp":1791978370033,"version":"4.4.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T00:00:00Z","timestamp":1586390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pharmthera.2020.107542","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T11:03:02Z","timestamp":1585825382000},"page":"107542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Novel insights into the organic solute transporter alpha\/beta, OST\u03b1\/\u03b2: From the bench to the bedside"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6926-8844","authenticated-orcid":false,"given":"James J.","family":"Beaudoin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-4929","authenticated-orcid":false,"given":"Kim L.R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-5043","authenticated-orcid":false,"given":"Melina M.","family":"Malinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107542_bb0005","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1053\/gast.2001.24804","article-title":"LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers","volume":"120","author":"Abe","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nature Methods"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejps.2017.02.011","article-title":"Identification of novel MRP3 inhibitors based on computational models and validation using an in vitro membrane vesicle assay","volume":"103","author":"Ali","year":"2017","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0020","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/17425255.2017.1389897","article-title":"In silico ADME-Tox modeling: Progress and prospects","volume":"13","author":"Alqahtani","year":"2017","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2016.04.014","article-title":"Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier","volume":"109","author":"Arana","year":"2016","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1113\/jphysiol.2003.060293","article-title":"Bidirectional substrate fluxes through the system N (SNAT5) glutamine transporter may determine net glutamine flux in rat liver","volume":"559","author":"Baird","year":"2004","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00424-006-0160-8","article-title":"Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1\/ABCC1)","volume":"453","author":"Bakos","year":"2007","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.106.107433","article-title":"Bias in estimation of transporter kinetic parameters from overexpression systems: Interplay of transporter expression level and substrate affinity","volume":"320","author":"Balakrishnan","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0045","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s11095-006-0219-4","article-title":"Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation","volume":"23","author":"Balakrishnan","year":"2006","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/153537020523001001","article-title":"Biology of a novel organic solute and steroid transporter, OSTalpha-OSTbeta","volume":"230","author":"Ballatori","year":"2005","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000324123","article-title":"Pleiotropic functions of the organic solute transporter Ostalpha-Ostbeta","volume":"29","author":"Ballatori","year":"2011","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0060","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.20961","article-title":"OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia","volume":"42","author":"Ballatori","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.mam.2012.11.005","article-title":"The heteromeric organic solute transporter, OSTalpha-OSTbeta\/SLC51: a transporter for steroid-derived molecules","volume":"34","author":"Ballatori","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0070","doi-asserted-by":"crossref","first-page":"G179","DOI":"10.1152\/ajpgi.90319.2008","article-title":"Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver","volume":"295","author":"Ballatori","year":"2008","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0075","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2741\/3416","article-title":"OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids","volume":"14","author":"Ballatori","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2164-7-142","article-title":"Centering, scaling, and transformations: improving the biological information content of metabolomics data","volume":"7","author":"van den Berg","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1124\/mol.111.075143","article-title":"Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta","volume":"81","author":"Blazquez","year":"2012","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0090","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1038\/s41598-018-23528-7","article-title":"Low affinity uniporter carrier proteins can increase net substrate uptake rate by reducing efflux","volume":"8","author":"Bosdriesz","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0095","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents","volume":"290","author":"Boyer","year":"2006","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-14541-4_2","article-title":"In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy","author":"Burckhardt","year":"2011","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0091270007311568","article-title":"P-glycoprotein: so many ways to turn it on","volume":"48","author":"Callaghan","year":"2008","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0115","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","article-title":"Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Cha","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0120","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","article-title":"Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta","volume":"275","author":"Cha","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120055","article-title":"Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction","volume":"10","author":"Chai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1471-4159.2011.07288.x","article-title":"Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells","volume":"118","author":"Chan","year":"2011","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/dmd.117.075606","article-title":"Derivation of a system-independent Ki for P-glycoprotein mediated digoxin transport from system-dependent IC50 data","volume":"46","author":"Chaudhry","year":"2018","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0140","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00498254.2010.523736","article-title":"Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors","volume":"41","author":"Choi","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0150","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1124\/jpet.111.179101","article-title":"1Alpha,25-dihydroxyvitamin D3 up-regulates P-glycoprotein via the vitamin D receptor and not farnesoid X receptor in both fxr(-\/-) and fxr(+\/+) mice and increased renal and brain efflux of digoxin in mice in vivo","volume":"337","author":"Chow","year":"2011","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.116.236935","article-title":"Disrupted murine gut-to-human liver signaling alters bile acid homeostasis in humanized mouse liver models","volume":"360","author":"Chow","year":"2017","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0160","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1042\/BCJ20161093","article-title":"Global functions of extracellular, transmembrane and cytoplasmic domains of organic solute transporter beta-subunit","volume":"474","author":"Christian","year":"2017","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0165","doi-asserted-by":"crossref","first-page":"21233","DOI":"10.1074\/jbc.M112.352245","article-title":"Beta-Subunit of the Ostalpha-Ostbeta organic solute transporter is required not only for heterodimerization and trafficking but also for function","volume":"287","author":"Christian","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0170","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.119.089656","article-title":"Quantitative proteomics of clinically relevant drug-metabolizing enzymes and drug transporters and their inter-correlations in the human small intestine","volume":"48","author":"Couto","year":"2020","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0175","first-page":"G157","article-title":"Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter","volume":"274","author":"Craddock","year":"1998","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0180","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1074\/jbc.M004968200","article-title":"Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6","volume":"276","author":"Cui","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb7000","first-page":"G371","article-title":"Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting","volume":"297","author":"Dahan","year":"2009","journal-title":"The American Journal of Physiology: Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0185","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1074\/jbc.M412752200","article-title":"The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter","volume":"280","author":"Dawson","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0190","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbalip.2010.06.002","article-title":"Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism","volume":"1801","author":"Dawson","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2014.11.022","article-title":"A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide","volume":"478","author":"Dong","year":"2015","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0205","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.28797","article-title":"In vivo disposition of doxorubicin is affected by mouse Oatp1a\/1b and human OATP1A\/1B transporters","volume":"135","author":"Durmus","year":"2014","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0210","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1128\/AEM.70.9.5323-5330.2004","article-title":"Role of hexose transport in control of glycolytic flux in Saccharomyces cerevisiae","volume":"70","author":"Elbing","year":"2004","journal-title":"Applied and Environmental Microbiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0215","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/17425255.2018.1480720","volume":"14","author":"Ellens","year":"2018","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.taap.2013.03.019","article-title":"ATP-dependent transport of statins by human and rat MRP2\/Mrp2","volume":"269","author":"Ellis","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/mol.112.077909","article-title":"The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor","volume":"82","author":"Eloranta","year":"2012","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb5010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/tpj.2015.55","article-title":"Variability in hepatic expression of organic anion transporter 7\/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors","volume":"16","author":"Emami Riedmaier","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2010.06920.x","article-title":"Neurosteroid transport by the organic solute transporter OSTalpha-OSTbeta","volume":"115","author":"Fang","year":"2010","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0235","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1093\/jas\/sky327","article-title":"Effects of dietary pectin on the profile and transport of intestinal bile acids in young pigs","volume":"96","author":"Fang","year":"2018","journal-title":"Journal of Animal Science"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcmgh.2018.01.006","article-title":"Organic solute transporter alpha-beta protects ileal enterocytes from bile acid-induced injury","volume":"5","author":"Ferrebee","year":"2018","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0245","series-title":"Drug transporters: Molecular characterization and role in drug disposition","first-page":"245","article-title":"Drug transport in the liver","author":"Ferslew","year":"2014"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0250","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/BJ20101904","article-title":"OAT2 catalyses efflux of glutamate and uptake of orotic acid","volume":"436","author":"Fork","year":"2011","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0260","doi-asserted-by":"crossref","first-page":"G912","DOI":"10.1152\/ajpgi.00479.2005","article-title":"Regulation of the mouse organic solute transporter alpha-beta, Ostalpha-Ostbeta, by bile acids","volume":"290","author":"Frankenberg","year":"2006","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0265","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0026-895X(24)12255-9","article-title":"Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat","volume":"59","author":"Funk","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0270","doi-asserted-by":"crossref","first-page":"F130","DOI":"10.1152\/ajprenal.00114.2013","article-title":"Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters","volume":"306","author":"Gai","year":"2014","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0275","article-title":"OSTalpha deficiency: A disorder with cholestasis, liver fibrosis and congenital diarrhea","author":"Gao","year":"2019","journal-title":"Hepatology."},{"key":"10.1016\/j.pharmthera.2020.107542_bb0280","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garcia-Canaveras","year":"2012","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0285","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Molecular Cell"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0290","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1158\/1078-0432.CCR-12-0761","article-title":"Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel","volume":"18","author":"de Graan","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0295","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1021\/mp300618a","article-title":"New insights into the carrier-mediated transport of estrone-3-sulfate in the Caco-2 cell model","volume":"10","author":"Grandvuinet","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0300","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1002\/jps.22632","article-title":"Interactions between organic anions on multiple transporters in Caco-2 cells","volume":"100","author":"Grandvuinet","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0305","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1124\/mol.106.026450","article-title":"Modification of OATP2B1-mediated transport by steroid hormones","volume":"70","author":"Grube","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0310","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.clpt.2006.09.010","article-title":"Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart","volume":"80","author":"Grube","year":"2006","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/dmd.106.011411","article-title":"Organic anion transporting polypeptide 2B1 and breast cancer resistance protein interact in the transepithelial transport of steroid sulfates in human placenta","volume":"35","author":"Grube","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2008.01.042","article-title":"Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3","volume":"584","author":"Gui","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0325","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.117.246033","article-title":"Farnesoid X receptor agonists obeticholic acid and chenodeoxycholic acid increase bile acid efflux in sandwich-cultured human hepatocytes: Functional evidence and mechanisms","volume":"365","author":"Guo","year":"2018","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0330","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","article-title":"The SLCO (former SLC21) superfamily of transporters","volume":"34","author":"Hagenbuch","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"issue":"Pt 2","key":"10.1016\/j.pharmthera.2020.107542_bb0335","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation","volume":"343","author":"Halestrap","year":"1999","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0340","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1021\/bi0205404","article-title":"Identification of a region of the ileal-type sodium\/bile acid cotransporter interacting with a competitive bile acid transport inhibitor","volume":"41","author":"Hallen","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0345","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbalip.2005.10.006","article-title":"Transport by vesicles of glycine- and taurine-conjugated bile salts and taurolithocholate 3-sulfate: a comparison of human BSEP with rat Bsep","volume":"1738","author":"Hayashi","year":"2005","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0350","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/mp9003089","article-title":"Effects of experimental setup on the apparent concentration dependency of active efflux transport in in vitro cell permeation experiments","volume":"7","author":"Heikkinen","year":"2010","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0355","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1124\/dmd.106.009290","article-title":"Drug-drug interaction between pitavastatin and various drugs via OATP1B1","volume":"34","author":"Hirano","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0360","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1074\/jbc.M305782200","article-title":"Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition","volume":"279","author":"Ho","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0365","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","article-title":"Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics","volume":"130","author":"Ho","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0370","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1023\/B:PHAM.0000041466.84653.8c","article-title":"Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin","volume":"21","author":"Hochman","year":"2004","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0375","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity","volume":"36","author":"Hofmann","year":"2004","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0380","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.2741\/3399","article-title":"The enterohepatic circulation of bile acids in mammals: Form and functions","volume":"14","author":"Hofmann","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0385","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cbpc.2008.03.005","article-title":"Arachidonic acid-induced expression of the organic solute and steroid transporter-beta (Ost-beta) in a cartilaginous fish cell line","volume":"148","author":"Hwang","year":"2008","journal-title":"Toxicology and Endocrinology Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.pharmthera.2020.107542_bb0390","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jhep.2016.01.016","article-title":"Gene expression profiling in human precision cut liver slices in response to the FXR agonist obeticholic acid","volume":"64","author":"Ijssennagger","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0395","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.64.3.610","article-title":"Breast cancer resistance protein exports sulfated estrogens but not free estrogens","volume":"64","author":"Imai","year":"2003","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0400","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: An ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0405","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ijc.28970","article-title":"Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel","volume":"136","author":"Iusuf","year":"2015","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aivt.2016.0023","article-title":"Basolateral efflux transporters: A potentially important pathway for the prevention of cholestatic hepatotoxicity","volume":"2","author":"Jackson","year":"2016","journal-title":"Applied In Vitro Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0415","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/jpet.111.187161","article-title":"Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 alpha\/beta and DNA methylation","volume":"340","author":"Jin","year":"2012","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0420","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11095-006-9135-x","article-title":"Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition","volume":"24","author":"Kalvass","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0425","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.fpc.0000170913.73780.5f","article-title":"Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells","volume":"15","author":"Kameyama","year":"2005","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0430","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2133\/dmpk.22.287","article-title":"Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA","volume":"22","author":"Kamiyama","year":"2007","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0435","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0440","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cpt.1222","article-title":"Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective","volume":"104","author":"Kenna","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0445","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/clpt.2009.79","article-title":"ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin","volume":"86","author":"Keskitalo","year":"2009","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0450","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/bdd.663","article-title":"Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver","volume":"30","author":"Khan","year":"2009","journal-title":"Biopharmaceutics & Drug Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0455","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.106.025494","article-title":"Regulation of the expression of human organic anion transporter 3 by hepatocyte nuclear factor 1alpha\/beta and DNA methylation","volume":"70","author":"Kikuchi","year":"2006","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0460","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0022-3565(24)35228-0","article-title":"Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity","volume":"291","author":"Kim","year":"1999","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0465","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.301.1.293","article-title":"Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins","volume":"301","author":"Kimura","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0470","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/BJ20060632","article-title":"Modulation of drug-stimulated ATPase activity of human MDR1\/P-glycoprotein by cholesterol","volume":"401","author":"Kimura","year":"2007","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0475","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1124\/dmd.108.024778","article-title":"Effect of membrane cholesterol on BSEP\/Bsep activity: species specificity studies for substrates and inhibitors","volume":"37","author":"Kis","year":"2009","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0480","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1124\/dmd.108.021410","article-title":"Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin","volume":"36","author":"Kitamura","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0485","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00341.2011","article-title":"Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule","volume":"302","author":"Kittayaruksakul","year":"2012","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb5005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/mol.110.065201","article-title":"The human organic anion transporter genes OAT5 and OAT7 are transactivated by hepatocyte nuclear factor-1\u03b1 (HNF-1\u03b1)","volume":"78","author":"Klein","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0490","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.103.051300","article-title":"Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane","volume":"306","author":"Kobayashi","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0495","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","article-title":"Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])","volume":"57","author":"Kobayashi","year":"2005","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0500","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1124\/dmd.107.016014","article-title":"Decrease in intracellular concentration causes the shift in Km value of efflux pump substrates","volume":"35","author":"Korjamo","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0505","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0022-2275(20)33406-4","article-title":"Substrate specificity of the ileal and the hepatic Na(+)\/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters","volume":"40","author":"Kramer","year":"1999","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0510","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","article-title":"Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes","volume":"305","author":"Krogh","year":"2001","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0515","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0014-5793(98)00168-9","article-title":"Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain","volume":"424","author":"Kullak-Ublick","year":"1998","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0520","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/gast.2001.21176","article-title":"Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver","volume":"120","author":"Kullak-Ublick","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0525","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nature Protocols"},{"key":"10.1016\/j.pharmthera.2020.107542_bb6000","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1476-5381.2012.01887.x","article-title":"Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP","volume":"166","author":"Kusuhara","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pharmthera.2020.107542_bb0530","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3610497","article-title":"Role of glutathione in the multidrug resistance protein 4 (MRP4\/ABCC4)-mediated efflux of cAMP and resistance to purine analogues","volume":"361","author":"Lai","year":"2002","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0535","doi-asserted-by":"crossref","first-page":"G476","DOI":"10.1152\/ajpgi.00430.2005","article-title":"The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes","volume":"290","author":"Landrier","year":"2006","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0540","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.clpt.6100038","article-title":"Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers","volume":"81","author":"Lau","year":"2007","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0545","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ejps.2013.01.005","article-title":"Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes","volume":"48","author":"Le Vee","year":"2013","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0550","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.116.105544","article-title":"Contribution of organic anion-transporting polypeptides 1A\/1B to doxorubicin uptake and clearance","volume":"91","author":"Lee","year":"2017","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0555","doi-asserted-by":"crossref","first-page":"9610","DOI":"10.1074\/jbc.M411092200","article-title":"Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry","volume":"280","author":"Lee","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0560","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0565","doi-asserted-by":"crossref","first-page":"C570","DOI":"10.1152\/ajpcell.00436.2008","article-title":"Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters","volume":"296","author":"Leuthold","year":"2009","journal-title":"American Journal of Physiology. Cell Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0570","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1124\/dmd.112.045666","article-title":"The role of a basolateral transporter in rosuvastatin transport and its interplay with apical breast cancer resistance protein in polarized cell monolayer systems","volume":"40","author":"Li","year":"2012","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0575","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BJ20070716","article-title":"Heterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporter","volume":"407","author":"Li","year":"2007","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0580","doi-asserted-by":"crossref","DOI":"10.1208\/ps010201","article-title":"Glycylsarcosine uptake in rabbit renal brush border membrane vesicles isolated from outer cortex or outer medulla: evidence for heterogeneous distribution of oligopeptide transporters","volume":"1","author":"Lin","year":"1999","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.pharmthera.2020.107542_bb5015","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21880","article-title":"Regulation of the placental BCRP transporter by PPAR gamma","volume":"31","author":"Lin","year":"2017","journal-title":"J Biochem Mol Toxicol."},{"key":"10.1016\/j.pharmthera.2020.107542_bb0585","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/toxsci\/kfu151","article-title":"Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures","volume":"141","author":"Liu","year":"2014","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0590","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/hq1201.100262","article-title":"Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia","volume":"21","author":"Love","year":"2001","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0595","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/toxsci\/kfq280","article-title":"Alterations in hepatic mRNA expression of phase II enzymes and xenobiotic transporters after targeted disruption of hepatocyte nuclear factor 4 alpha","volume":"118","author":"Lu","year":"2010","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0600","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/jpet.114.219287","article-title":"Effects of beta-blockers and tricyclic antidepressants on the activity of human organic anion transporting polypeptide 1A2 (OATP1A2)","volume":"352","author":"Lu","year":"2015","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/mp050063u","article-title":"Uptake of ursodeoxycholate and its conjugates by human hepatocytes: role of Na(+)-taurocholate cotransporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1 (OATP-C), and oatp1B3 (OATP8)","volume":"3","author":"Maeda","year":"2006","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0610","first-page":"539","article-title":"Characterisation of glucose transport in Saccharomyces cerevisiae with plasma membrane vesicles (countertransport) and intact cells (initial uptake) with single Hxt1, Hxt2, Hxt3, Hxt4, Hxt6, Hxt7 or Gal2 transporters","volume":"2","author":"Maier","year":"2002","journal-title":"FEMS Yeast Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0615","doi-asserted-by":"crossref","first-page":"G597","DOI":"10.1152\/ajpgi.00310.2017","article-title":"Organic solute transporter OSTalpha\/beta is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury","volume":"314","author":"Malinen","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.pharmthera.2020.107542_bb0620","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejps.2019.01.022","article-title":"Protein expression and function of organic anion transporters in short-term and long-term cultures of Huh7 human hepatoma cells","volume":"130","author":"Malinen","year":"2019","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0625","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1021\/acs.molpharmaceut.8b00966","article-title":"Novel in vitro method reveals drugs that inhibit organic solute transporter alpha\/beta (OSTalpha\/beta)","volume":"16","author":"Malinen","year":"2019","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0630","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.510260641","article-title":"Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver","volume":"26","author":"Meier","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0635","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/0008-5472.CAN-05-1070","article-title":"Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma","volume":"66","author":"Miki","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0640","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1073\/pnas.0304987101","article-title":"Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney","volume":"101","author":"Mikkaichi","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0645","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1124\/dmd.110.036863","article-title":"Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice","volume":"39","author":"Miyajima","year":"2011","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0650","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1248\/bpb.b14-00640","article-title":"Antibacterial drug treatment increases intestinal bile acid absorption via elevated levels of ileal apical sodium-dependent bile acid transporter but not organic solute transporter alpha protein","volume":"38","author":"Miyata","year":"2015","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0655","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1681\/ASN.2005030306","article-title":"Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins","volume":"16","author":"Miyazaki","year":"2005","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0660","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0665","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0670","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.3377","article-title":"Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate","volume":"275","author":"Nishio","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0675","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1124\/dmd.106.012930","article-title":"Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3","volume":"35","author":"Noe","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0680","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.103.060194","article-title":"Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human","volume":"308","author":"Nozawa","year":"2004","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0685","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.113.206359","article-title":"Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene","volume":"347","author":"O\u2019Brien","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0690","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00535-006-1784-3","article-title":"Farnesoid X receptor, hepatocyte nuclear factors 1alpha and 3beta are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene","volume":"41","author":"Ohtsuka","year":"2006","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0695","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11095-006-9163-6","article-title":"LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR","volume":"24","author":"Okuwaki","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0700","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/10408444.2016.1149452","article-title":"Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis","volume":"46","author":"Onakpoya","year":"2016","journal-title":"Critical Reviews in Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0705","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0710","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00204-019-02643-y","article-title":"Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes","volume":"94","author":"Petrov","year":"2020","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0715","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1124\/jpet.113.208314","article-title":"Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liver","volume":"347","author":"Pfeifer","year":"2013","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0720","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jc.2003-030174","article-title":"Identification of steroid sulfate transport processes in the human mammary gland","volume":"88","author":"Pizzagalli","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0725","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1124\/mol.104.010223","article-title":"The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids","volume":"67","author":"Popowski","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0730","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1074\/jbc.M008251200","article-title":"Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1","volume":"276","author":"Qian","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0735","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0740","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1073\/pnas.1033060100","article-title":"The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs","volume":"100","author":"Reid","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0745","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr407","article-title":"Predicting the functional impact of protein mutations: application to cancer genomics","volume":"39","author":"Reva","year":"2011","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0750","doi-asserted-by":"crossref","first-page":"G640","DOI":"10.1152\/ajpgi.00354.2005","article-title":"Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione","volume":"290","author":"Rius","year":"2006","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0755","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0760","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/dmd.119.089615","article-title":"Induction of human intestinal and hepatic organic anion transporting polypeptides; where is the evidence for its relevance in drug-drug interactions?","volume":"48","author":"Rodrigues","year":"2019","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0765","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.105.099929","article-title":"The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha","volume":"317","author":"Saborowski","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0770","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0775","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/liv.12558","article-title":"The organic solute transporters alpha and beta are induced by hypoxia in human hepatocytes","volume":"35","author":"Schaffner","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0780","series-title":"Intestinal and hepatic drug transporters and their role in the disposition of lipid-lowering drugs","first-page":"81","article-title":"The bile acid transporter organic solute transporter (OST) alpha-beta is also an intestinal drug transporter","author":"Schwarz","year":"2012"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0785","doi-asserted-by":"crossref","first-page":"27473","DOI":"10.1074\/jbc.M301106200","article-title":"Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta","volume":"278","author":"Seward","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0790","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1124\/dmd.114.062364","article-title":"Characterization of organic anion transporter 2 (SLC22A7): A highly efficient transporter for creatinine and species-dependent renal tubular expression","volume":"43","author":"Shen","year":"2015","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0795","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1349-7006.1999.tb00723.x","article-title":"Interaction of docetaxel (\"Taxotere\") with human P-glycoprotein","volume":"90","author":"Shirakawa","year":"1999","journal-title":"Japanese Journal of Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0800","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.118.114827","article-title":"Severe hepatotoxicity of mithramycin therapy caused by altered expression of hepatocellular bile transporters","volume":"96","author":"Sissung","year":"2019","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0805","doi-asserted-by":"crossref","first-page":"23530","DOI":"10.1074\/jbc.M909002199","article-title":"MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping","volume":"275","author":"Smith","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0810","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1055\/s-0030-1253226","article-title":"Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis","volume":"30","author":"Soroka","year":"2010","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0815","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.23265","article-title":"Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis","volume":"51","author":"Soroka","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0820","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2121-9-57","article-title":"N-Glycosylation of the alpha subunit does not influence trafficking or functional activity of the human organic solute transporter alpha\/beta","volume":"9","author":"Soroka","year":"2008","journal-title":"BMC Cell Biology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0825","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s10620-005-2719-1","article-title":"A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease","volume":"50","author":"Sorrentino","year":"2005","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0830","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/B978-0-12-800223-0.00005-0","article-title":"Organic anion-transporting polypeptides","volume":"73","author":"Stieger","year":"2014","journal-title":"Current Topics in Membranes"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0835","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbamem.2019.03.003","article-title":"Characterization of conjugated and unconjugated bile acid transport via human organic solute transporter alpha\/beta","volume":"1861","author":"Suga","year":"2019","journal-title":"Biochimica et Biophysica Acta - Biomembranes"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169719","article-title":"Preference of conjugated bile acids over unconjugated bile acids as substrates for OATP1B1 and OATP1B3","volume":"12","author":"Suga","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0850","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.29516","article-title":"Organic solute transporter-beta (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis","volume":"68","author":"Sultan","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0855","doi-asserted-by":"crossref","first-page":"G1586","DOI":"10.1152\/ajpgi.00457.2006","article-title":"Protein-protein interactions and membrane localization of the human organic solute transporter","volume":"292","author":"Sun","year":"2007","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0860","first-page":"290","article-title":"Human Organic Solute Transporter (hOST): Protein interaction and membrane sorting process","volume":"3","author":"Sun","year":"2012","journal-title":"International Journal of Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0865","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/jps.22641","article-title":"Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease","volume":"100","author":"Suzuki","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0870","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11095-009-0026-9","article-title":"Model analysis of the concentration-dependent permeability of P-gp substrates","volume":"27","author":"Tachibana","year":"2010","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0875","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2007.04.010","article-title":"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions\/H(+)-organic cation antiporters","volume":"74","author":"Tanihara","year":"2007","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0880","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.287.17.2273","article-title":"Safety of newly approved drugs: implications for prescribing","volume":"287","author":"Temple","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0885","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","article-title":"Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis","volume":"151","author":"Teng","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pharmthera.2020.107542_bb0890","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.bcp.2007.12.008","article-title":"Physiological and pharmacokinetic roles of H+\/organic cation antiporters (MATE\/SLC47A)","volume":"75","author":"Terada","year":"2008","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0895","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/01.mcg.0000155551.37266.26","article-title":"Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis","volume":"39","author":"Trauner","year":"2005","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0900","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1023\/A:1025049014674","article-title":"Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers","volume":"20","author":"Troutman","year":"2003","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0905","doi-asserted-by":"crossref","first-page":"F593","DOI":"10.1152\/ajprenal.00312.2006","article-title":"Oppositely directed H+ gradient functions as a driving force of rat H+\/organic cation antiporter MATE1","volume":"292","author":"Tsuda","year":"2007","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0910","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0915","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/FPC.0b013e3282f974dc","article-title":"Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe","volume":"18","author":"Urquhart","year":"2008","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0920","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.M109.014803","article-title":"Asparagine-linked oligosaccharides present on a non-consensus amino acid sequence in the CH1 domain of human antibodies","volume":"284","author":"Valliere-Douglass","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0925","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mce.2009.08.003","article-title":"Study of the transport of thyroid hormone by transporters of the SLC10 family","volume":"315","author":"Visser","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0930","first-page":"228","article-title":"Investigating transporter-mediated drug-drug interactions using a physiologically based pharmacokinetic model of rosuvastatin","volume":"6","author":"Wang","year":"2017","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0935","doi-asserted-by":"crossref","first-page":"9431","DOI":"10.1073\/pnas.161099898","article-title":"Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate","volume":"98","author":"Wang","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0940","first-page":"131","article-title":"Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models","volume":"19","author":"Weaver","year":"2019","journal-title":"Nature Reviews: Drug Discovery"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0945","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jcmgh.2017.11.011","article-title":"Intestinal Farnesoid X receptor activation by pharmacologic inhibition of the organic solute transporter \u03b1-\u03b2","volume":"5","author":"van de Wiel","year":"2018","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0950","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/jpet.107.125831","article-title":"The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin","volume":"322","author":"Windass","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0955","article-title":"A Novel Di-Leucine Motif at the N-terminus of human organic solute transporter beta is essential for protein association and membrane localization","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0960","doi-asserted-by":"crossref","first-page":"G154","DOI":"10.1152\/ajpgi.00138.2013","article-title":"A novel RARalpha\/CAR-mediated mechanism for regulation of human organic solute transporter-beta gene expression","volume":"306","author":"Xu","year":"2014","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0965","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.107.017459","article-title":"Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor","volume":"35","author":"Yamada","year":"2007","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0970","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2007.10.040","article-title":"Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes","volume":"260","author":"Yamaguchi","year":"2008","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0975","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2133\/dmpk.25.314","article-title":"Transport of estrone 3-sulfate mediated by organic anion transporter OATP4C1: estrone 3-sulfate binds to the different recognition site for digoxin in OATP4C1","volume":"25","author":"Yamaguchi","year":"2010","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0980","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1211\/jpp.58.11.0011","article-title":"Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4","volume":"58","author":"Yamashita","year":"2006","journal-title":"The Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0985","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1124\/jpet.114.221564","article-title":"Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury","volume":"353","author":"Yang","year":"2015","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0990","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cpt.1112","article-title":"Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107542_bb0995","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj20021886","article-title":"Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)","volume":"371","author":"Zelcer","year":"2003","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107542_bb1000","first-page":"4779","article-title":"Transport of amphipathic anions by human multidrug resistance protein 3","volume":"60","author":"Zeng","year":"2000","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2020.107542_bb1005","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1021\/bi034462b","article-title":"Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3","volume":"42","author":"Zhang","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2020.107542_bb1010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1124\/mol.65.5.1141","article-title":"The role of glycine residues in the function of human organic anion transporter 4","volume":"65","author":"Zhou","year":"2004","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107542_bb1015","doi-asserted-by":"crossref","first-page":"G923","DOI":"10.1152\/ajpgi.00490.2005","article-title":"Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha\/beta in the adaptive response to bile acids","volume":"290","author":"Zollner","year":"2006","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582030070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582030070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:05:53Z","timestamp":1759010753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582030070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":207,"alternative-id":["S016372582030070X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107542","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into the organic solute transporter alpha\/beta, OST\u03b1\/\u03b2: From the bench to the bedside","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107542"}}